Tumor-activatable ultrasmall nanozyme generator for enhanced penetration and deep catalytic therapy

Xinping Liu,Zhengwei Liu,Kai Dong,Si Wu,Yanjuan Sang,Tingting Cui,Ya Zhou,Jinsong Ren,Xiaogang Qu
DOI: https://doi.org/10.1016/j.biomaterials.2020.120263
IF: 14
2020-11-01
Biomaterials
Abstract:<p>Tumor-activatable ultrasmall nanozyme generation is an unprecedented strategy to overcome intrinsically fatal defects of traditional reactive oxygen species (ROS)-based nanoagents for deep tumor penetration, including limited tissue-penetrating depth of external energy, heavy reliance on oxygen and nonspecific toxicity of therapeutic agents. Here, based on the cascade reaction between glucose oxidase (GOx) and ultrasmall peroxidase nanozyme embedded into acid-dissociable zeolitic imidazolate framework-8 (ZIF-8), such a tumor-activatable ultrasmall nanozyme generator is designed for enhanced penetration and deep catalytic therapy. With the aid of mildly acidic tumor microenvironment, the produced gluconic acid from intratumoral glucose can gradually induce the dissociation of ZIF-8 to release ultrasmall peroxidase nanozyme with significant intratumoral penetration. On the other hand, the generated hydrogen peroxide with relatively long-life can be subsequently catalyzed by penetrated peroxidase nanozyme into toxic hydroxyl radicals for deep catalytic therapy. In this way, the well-designed nanoplatform not only can greatly enhance tumor penetration but also directly induce exogenous ROS without oxygen participation and external energy input, thereby thoroughly avoiding the inactivation of traditional ROS-based nanoagents in the extremely hypoxic tumor center and finally resulting in remarkable deep catalytic therapy.</p>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the insufficient deep - tumor - penetration ability, strong oxygen - dependence and non - specific toxicity of traditional reactive oxygen species (ROS) - based nano - therapeutics. Specifically, due to the limited tissue - penetration depth, high dependence on oxygen and reliance on external energy input, traditional ROS - based nano - therapeutic systems are ineffective in the extremely hypoxic central regions of tumors and may cause non - specific damage to normal tissues. These problems limit the clinical application effectiveness of these therapeutic systems. To solve the above problems, the research team designed a tumor - activated ultrasmall nano - enzyme generator (ZIF@GOx/GQDs). Through a cascade reaction, hydrogen peroxide (\(\text{H}_2\text{O}_2\)) is generated in the tumor microenvironment and then catalyzed and converted into toxic hydroxyl radicals (\(\cdot\text{OH}\)) by the released ultrasmall nano - enzymes, achieving catalytic therapy for deep - seated tumors. This design not only enhances the tumor - penetration ability of nanoparticles but also can directly induce the generation of exogenous ROS without relying on external stimulation and oxygen participation, thereby avoiding the inactivation problem of traditional ROS - based nano - therapeutics in the extremely hypoxic central regions of tumors and finally achieving a remarkable deep - seated catalytic therapy effect.